FDA Import Refusal 112-8442116-3/2/1 — Glaxosmith Kline
The FDA refused shipment 112-8442116-3/2/1 from Glaxosmith Kline (Philippines) on Oct 11, 2007. The refused product falls under Drugs and Biologics — CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 11, 2007
- Country
- Philippines
- Product Category
- Drugs and Biologics
- Product Code
- 61XAB45 CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
- Charges
- 75